Our ClientFoRx Therapeutics is a preclinical, privately held company based in Basel, Switzerland. FoRx focuses on drugging key molecular targets involved in the DNA Replication Stress pathway, as a new approach in the development of targeted anti-cancer drugs. The company is backed by a strong syndicate of investors that include the Novartis Venture Fund, Pfizer Ventures, M Ventures, Omega Funds and LSP Venture Capital. Location: Basel, Novartis Campus. For the extension of our internal computational chemistry capabilities, we are looking for a
We are looking forwards receiving your application.